FierceBiotech 25. Nov. 2025 <a href="https://www.fiercebiotech.com/biotech/bayers-asundexian-cuts-stroke-risk-phase-3-reviving-hopes-fxia-class" hreflang="en">Bayer's asundexian cuts stroke risk in phase 3, reviving hopes for FXIa class</a> #Bayer asundexian #reviving hopes
Nature News 25. Nov. 2025 Hepatic zonation determines tumorigenic potential of mutant β-catenin #Published online #β-catenin Nature
Endpoints News 21. Nov. 2025 FDA investigates child death potentially related to Takeda's enzyme replacement therapy #FDA investigates #blood disorder
Roche Media 17. Nov. 2025 Roche Gives Glimpse of Cancer Genomics Potential of New Axelios Sequencer - GenomeWeb #Cancer Genomics #Genomics Potential
PharmaVoice 17. Nov. 2025 Developing a path forward in cancer cachexia #Pfizer scientists #cachexia Pfizer
Thermo Fisher 2. Sept. 2025 Thermo Fisher Scientific's Valuation: Assessing Growth Potential After New Facility and Nalgene Product Launches - Yahoo Finance #Scientific Valuation #Assessing Growth
Cytiva (Google News) 15. Apr. 2025 Unlocking the Potential of PROTACs in Drug Discovery - Technology Networks #Drug Discovery #Technology Networks